The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma

Massimo Martino, Violetta Marafioti, Martina Pitea, Gaetana Porto, Giorgia Policastro, Filippo Antonio Canale, Virginia Naso, Caterina Alati

Open source

DOI
10.3390/cancers18152513
Published
2026-08-05
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18152513,
  title = {The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma},
  author = {Massimo Martino and Violetta Marafioti and Martina Pitea and Gaetana Porto and Giorgia Policastro and Filippo Antonio Canale and Virginia Naso and Caterina Alati},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18152513},
  url = {https://doi.org/10.3390/cancers18152513}
}

RIS

TY  - JOUR
TI  - The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma
AU  - Massimo Martino
AU  - Violetta Marafioti
AU  - Martina Pitea
AU  - Gaetana Porto
AU  - Giorgia Policastro
AU  - Filippo Antonio Canale
AU  - Virginia Naso
AU  - Caterina Alati
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18152513
UR  - https://doi.org/10.3390/cancers18152513
ER  - 

APA

Martino, M., Marafioti, V., Pitea, M., Porto, G., Policastro, G., Canale, F. A., Naso, V., & Alati, C. (2026). The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma. Cancers. https://doi.org/10.3390/cancers18152513

Source records